Form 8-K - Current report:
SEC Accession No. 0001493152-20-019099
Filing Date
2020-10-07
Accepted
2020-10-07 16:55:22
Documents
1
Period of Report
2020-10-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 36261
  Complete submission text file 0001493152-20-019099.txt   37630
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 201229539
SIC: 7389 Services-Business Services, NEC